194 related articles for article (PubMed ID: 18204353)
21. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.
Volonteri LS; Colasanti A; Cerveri G; Fiorentini A; De Gaspari IF; Mauri MC; Valli A; Papa P; Mencacci C
J Psychopharmacol; 2010 Aug; 24(8):1193-9. PubMed ID: 19406851
[TBL] [Abstract][Full Text] [Related]
23. A case of apical ballooning cardiomyopathy associated with duloxetine.
Bergman BR; Reynolds HR; Skolnick AH; Castillo D
Ann Intern Med; 2008 Aug; 149(3):218-9. PubMed ID: 18678857
[No Abstract] [Full Text] [Related]
24. [Physical recovery is part of remission].
Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
[No Abstract] [Full Text] [Related]
25. A case of hyponatremia induced by duloxetine.
Safdieh JE; Rudominer R
J Clin Psychopharmacol; 2006 Dec; 26(6):675-6. PubMed ID: 17110834
[No Abstract] [Full Text] [Related]
26. Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study.
Bellino S; Paradiso E; Bozzatello P; Bogetto F
J Psychopharmacol; 2010 Mar; 24(3):333-9. PubMed ID: 18719047
[TBL] [Abstract][Full Text] [Related]
27. Hypogonadism and gynecomastia with duloxetine.
Weydt P; Schönfeldt-Lecuona CJ; Gahr M; Connemann BJ
Pharmacopsychiatry; 2011 Mar; 44(2):77. PubMed ID: 21298612
[No Abstract] [Full Text] [Related]
28. Serotonin-norepinephrine reuptake inhibitor treatment for tinnitus and depression.
Chang JP; Wu CC
J Clin Psychopharmacol; 2012 Oct; 32(5):729. PubMed ID: 22926618
[No Abstract] [Full Text] [Related]
29. Suicidal ideation associated with duloxetine use: a case series.
Parikh AR; Thatcher BT; Tamano EA; Liskow BI
J Clin Psychopharmacol; 2008 Feb; 28(1):101-2. PubMed ID: 18204351
[No Abstract] [Full Text] [Related]
30. Duloxetine--three birds with one stone?
Michel MC
Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
[No Abstract] [Full Text] [Related]
31. Serotonin-norepinephrine reuptake inhibitor-associated mixed episode in an adolescent with schizoaffective disorder.
Chang JP; Chi MH; Chiu YN; Tsai WC; Gau SS; Shang CY
J Clin Psychopharmacol; 2014 Aug; 34(4):525-6. PubMed ID: 24875069
[No Abstract] [Full Text] [Related]
32. Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine.
Pitchot W; Scantamburlo G; Ansseau M
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S106-7. PubMed ID: 21057413
[TBL] [Abstract][Full Text] [Related]
33. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
[TBL] [Abstract][Full Text] [Related]
34. The use of Duloxetine in the treatment of male stress urinary incontinence.
Fink KG; Huber J; Würnschimmel E; Schmeller NT
Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
[TBL] [Abstract][Full Text] [Related]
35. Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study.
Seguí J; López-Muñoz F; Alamo C; Camarasa X; García-García P; Pardo A
J Psychopharmacol; 2010 Aug; 24(8):1201-7. PubMed ID: 19282423
[TBL] [Abstract][Full Text] [Related]
36. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
Nordström G; Despiegel N; Marteau F; Danchenko N; Maman K
J Med Econ; 2010; 13(3):516-26. PubMed ID: 20698748
[TBL] [Abstract][Full Text] [Related]
37. Duloxetine in the treatment of social anxiety disorder.
Crippa JA; Filho AS; Freitas MC; Zuardi AW
J Clin Psychopharmacol; 2007 Jun; 27(3):310. PubMed ID: 17502786
[No Abstract] [Full Text] [Related]
38. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
[TBL] [Abstract][Full Text] [Related]
39. [Duloxetine, a new therapeutic option for diabetic peripheral neuropathic pain].
Ziegler D
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S284-8. PubMed ID: 17139588
[TBL] [Abstract][Full Text] [Related]
40. Serotonin syndrome induced by duloxetine.
Hadikusumo B; Ng B
Aust N Z J Psychiatry; 2009 Jun; 43(6):581-2. PubMed ID: 19452666
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
